The University of Alabama at Birmingham
The University of Alabama at Birmingham
Birmingham, Alabama, United States17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Enrolling by invitation | Phase 3 | 2026-10-06 | NCT04905693 | |
| A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, blood platelet disease, hematologic disorder, neonatal thrombocytopenia, thrombocytopenia | Recruiting | Phase 3 | 2026-09-25 | NCT06533098 | |
| A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-09-25 | NCT05453903 | |
| Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, primary peritoneal carcinoma | Recruiting | Phase 2 | 2026-09-14 | NCT06787612 | |
| DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-09 | NCT07288112 | |
| Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation | Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, anemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-09-02 | NCT07249346 | |
| Lead Evaluation for Defibrillation and Reliability Post Approval Study | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachyarrhythmia, Tachycardia, cardiovascular disorder, heart disorder | Enrolling by invitation | Not stated | 2026-08-03 | NCT07005232 | |
| A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 1 | 2026-07-01 | NCT06315257 | |
| Ensuring Access to Optimal Therapy in CF: The ENACT Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Phase 4 | 2026-06-02 | NCT07148739 | |
| The Nuestros Días ("Our Days") Study | anxiety, anxiety disorder, depressive disorder, psychiatric disorder | Active, not recruiting | Not stated | 2026-05-29 | NCT06475534 | |
| Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy | Embolism, Embolism and Thrombosis, cardiovascular disorder, lung disorder, pulmonary embolism, respiratory system disorder, vascular disorder | Recruiting | Phase 3 | 2026-05-18 | NCT05591118 | |
| The Impact of Brief Behavioral Treatment for Insomnia Versus Brief Mindfulness Treatment on Cognition and Sleep Health in Adults (Age 50+) With HIV | Alzheimer disease, Dyssomnias, Sleep Disorders, Intrinsic, brain disorder, central nervous system disorder, cognitive disorder, dementia, insomnia, nervous system disorder, neurodegenerative disease, psychiatric disorder, sleep-wake disorder, tauopathy | Not yet recruiting | Not applicable | 2026-05-08 | NCT07272863 | |
| VENTURI (VENTilation Using Respiratory Imaging) | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-04-13 | NCT07282886 | |
| Bodewell Products for the Treatment of Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 4 | 2026-03-02 | NCT05566262 | |
| Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Recruiting | Phase 3 | 2026-02-09 | NCT05026749 | |
| Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™ | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Erythroplasia, Keratoderma, Palmoplantar, Keratoderma, Palmoplantar, Diffuse, Keratoderma, Palmoplantar, Epidermolytic, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Stomatognathic Diseases, disease, hereditary disease, hereditary skin disorder, hyperplasia, keratosis, leukoplakia, mouth disorder, neoplasm, precancerous condition, skin disorder | Recruiting | Not stated | 2024-11-07 | NCT05853783 | |
| Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Active, not recruiting | Phase 3 | 2024-10-01 | NCT05995405 |